🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

Adtalem Arm Partners With Dillard, Boosts Physician Diversity

Published 06/26/2019, 09:41 PM
Updated 07/09/2023, 06:31 AM
ATGE
-
STRA
-
BFAM
-
YOGAQ
-

In order to increase the numbers of African-American doctors in the United States, Adtalem Global Education Inc.‘s (NYSE:ATGE) Ross University School of Medicine (“RUSM”) has partnered with Louisiana-based Dillard University.

Per the agreement, eligible Dillard students will be able to receive a scholarship for the first semester covering full tuition in the medical school. They will also have to spend their initial two years of school at the RUSM campus in Barbados.

Adtalem’s Commitment to Address Diversity in Medicine

RUSM — one of the medical and veterinary schools of Adtalem — has a diverse student population, of which nearly one-fourth of the total students are African-American and Hispanic. Of the total U.S. physicians, African Americans make up only 6%. Notably, RUSM African-American graduates were more than 80 students, surpassing the average of eight in most U.S. medical schools.

On that note, RUSM recently agreed upon a similar partnership with Charles Drew University of Medicine and Science, Agricultural and Mechanical University, as well as Tuskegee University. Also, the company entered into the Historically Black Colleges and Universities (“HBCU”) Partnership Challenge, created by the Congressional Bipartisan HBCU Caucus, to increase diversity in key workforce sectors.

Tie-ups with corporations, hospitals, government agencies and professional organizations enabled the company to reduce exposure to Title IV funding.

Coming to price performance, shares of Adtalem have declined 5.6% so far this year against its industry’s 30.8% growth. The company has been recording lower profits over the last few quarters. The declining earnings were mainly due to certain restructuring charges related to the closing of the Ross University School of Medicine campus in Dominica and real estate consolidations.



Nevertheless, collaborations and strategic initiatives taken up by Adtalem will probably help to spur growth and regain momentum. Notably, in the second quarter of fiscal 2019, growth of new student enrollment was 4.9% and that of total student enrollment was 2.9% year over year. The company remains optimistic about the demand trend in the medical and healthcare segment from both students and employees.

Zacks Rank & Key Picks

Currently, Adtalem carries a Zacks Rank #4 (Sell). Some better-ranked stocks in the same space include Strategic Education, Inc. (NASDAQ:STRA) , YogaWorks, Inc. (NASDAQ:YOGA) and Bright Horizons Family Solutions Inc. (NYSE:BFAM) . While Strategic Education and YogaWorks sport a Zacks Rank #1 (Strong Buy), Bright Horizons carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Strategic Education, YogaWorks and Bright Horizons’ earnings for the current year are expected to grow 36.2%, 17.1%, and 12.8%, respectively.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Bright Horizons Family Solutions Inc. (BFAM): Free Stock Analysis Report

Strategic Education Inc. (STRA): Free Stock Analysis Report

Adtalem Global Education Inc. (ATGE): Free Stock Analysis Report

YogaWorks, Inc. (YOGA): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.